Chantix

Chantix (varenicline) is a prescription medication used to treat smoking addiction

Chantix is a prescription medication used to treat smoking addiction. Chantix was approved in May of 2006 in the U.S. as an aid to smoking cessation. It has been prescribed to more than 4 million patients in the United States since its approval. is the first non-nicotine prescription treatment for smoking cessation in almost a decade.

, is a selective nicotinic acetylcholine receptor partial agonist. As a partial agonist, it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products, and through these mechanisms, it can assist some patients in stopping smoking.

Do you have a claim?

If your loved one has suffered a serious injury or death as a result of a side effect of , you may be entitled to compensation for medical expenses, loss of wages, and pain and suffering.

Please contact our Chantix lawyers today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost, no-obligation legal evaluation of your case.

Latest News

Support group says Chantix ads conceal important information

snuffedWhyQuit, an organization that advocates quitting smoking using the cold turkey method, recently published an article that takes to task over its latest Chantix ads. The group claims that the pharmaceutical company’s new television commercials hide information from the viewer – information that, if known, would likely dissuade most smokers from using the drug as a smoking cessation aid.

Read the rest of this entry »

Reynolds closer to buying smoking cessation products company

zonnic 100x100Reynolds American, the second largest American producer of cigarettes and other tobacco products, is in the advanced stages of negotiating a purchase of Niconovum, a Swedish company that manufactures smoking cessation products. If the deal works, as it appears it will, it shows the determination of the tobacco giants to cash in on the “whole cycle of a smoker from the first puff to the last piece of gum,” said Chip Brian, a business analyst for SmarTrend.

Read the rest of this entry »

“very low nicotine” cigarettes may become sound alternative to Chantix

tobacco 100x100It’s difficult for some coffee drinkers to imagine life before decaf. Pretty soon it may be difficult for some smokers to imagine life before de-nic. A New York company called 22nd Century Limited recently announced that it is making progress in its development of a very low nicotine (VLN) cigarette that uses a specially engineered and proprietary form of tobacco.

Read the rest of this entry »